Digital Health: Apps, Analytics & AgenciesDavid Harlow
Introduction to Digital Health presented at the Massachusetts Bar Association "Hot Topics in Healthcare" program on December 10, 2013. For more information, see related posts at HealthBlawg.com.
Internet Partner Notification: approaches, challenges and future steps. Presentation given by DaviJason Asselin at the AFAO National Syphilis Forum, 23 October 2009.
7 legal issues associated with telemedicine servicesmosmedicalreview
Like traditional medicine, telehealth also involves medical chart reviews and other investigations. There are certain legal issues related to telemedicine.
Leveraging Social Media for Healthcare ProvidersGreenway Health
Eighty-one percent of Americans look for health information online- but from whom are they getting it? Social media gives providers the opportunity to influence the information their patients are reading online and to engage them in a meaningful conversation. Learn how to utilize these technologies to improve patient communication, outcomes and even your bottom line.
Digital Health: Apps, Analytics & AgenciesDavid Harlow
Introduction to Digital Health presented at the Massachusetts Bar Association "Hot Topics in Healthcare" program on December 10, 2013. For more information, see related posts at HealthBlawg.com.
Internet Partner Notification: approaches, challenges and future steps. Presentation given by DaviJason Asselin at the AFAO National Syphilis Forum, 23 October 2009.
7 legal issues associated with telemedicine servicesmosmedicalreview
Like traditional medicine, telehealth also involves medical chart reviews and other investigations. There are certain legal issues related to telemedicine.
Leveraging Social Media for Healthcare ProvidersGreenway Health
Eighty-one percent of Americans look for health information online- but from whom are they getting it? Social media gives providers the opportunity to influence the information their patients are reading online and to engage them in a meaningful conversation. Learn how to utilize these technologies to improve patient communication, outcomes and even your bottom line.
To Prepare· Review the Congress website provided in the ResourcTakishaPeck109
To Prepare:
· Review the Congress website provided in the Resources and identify one recent (within the past 5 years) proposed health policy.
· Review the health policy you identified and reflect on the background and development of this health policy.
Post a description of the health policy you selected and a brief background for the problem or issue being addressed. Explain whether you believe there is an evidence base to support the proposed policy and explain why. Be specific and provide examples.
APA format and 3 references
Then respond to a peer with 2 references
Peer 1
The healthcare policy I chose is S. 3098, S.3098 -is the Preventive Care Awareness Act of 2021.
S. 3098 will provide national public health information and focus on people in a lower income bracket who have forgone services during the COVID-19 pandemic. This bill would also create a task force to promote preventative care and development programs in rural and underserved populations. Its primary focus is teaching low-income Americans the benefits of preventive healthcare. This bill is in committee and has bipartisan support (Bell et al., 2017).
Reading this proposed bill, I asked myself whether it is lower-income Americans who have forgone preventative treatment during COVID or Americans in general. Preventive screenings have long been advocated as one of the most valuable ways to facilitate early diagnosis and treatment of disease. Cancer screenings have helped lower the US cervical cancer death rate by 50% in the last three decades (2022).
According to the American Medical Association, more than 40% of Americans surveyed stopped preventative medical care as covid-19 began (Timothy M. Smith, Senior News Writer, 2020). This number included Americans of all economic levels. I believe no proof was found that only lower-income Americans skipped screenings during the height of the COVID-19 pandemic.
According to the Joint Commission, patients with lower health literacy did not see the importance of preventative care during COVID-19 (The Joint Commission, 2022). I believe there is evidence-based support for increasing education for all Americans regarding the importance of preventive health screenings, And indeed more teaching to Americans with a lower understanding of their health. This bill was given only a 3% chance of passing into law. I believe that is partly because it only attempts to reach lower-income populations and not all Americans.
50 words minimum each response
R1
I had a hard time with this question. I'd like to believe that all, if not most, health care providers have very high empathy, which would cause them to be sensitive toward patients. However, many different people with different personalities become health providers, and laws and regulations provide boundaries for most people. I believe if left alone, healthcare professionals and other professionals would choose what is most convenient for them and not what is best for the patie ...
Patients Rising: How to Reach Empowered, Digital Health Consumerse-Patient Connections
Kru Research's white paper discussing how to reach out to empowered, digital, health consumers or e-Patients. Discussion of participatory medicine, digital health consumers, e-Patients, web 2.0, the power of social media, ROI of social media, regulatory concerns, HIPAA, FDA, adverse event reporting, and the future of social media in health marketing.
CHAPTER 9 CONSENTConsent is an ethical imperative of great impo.docxchristinemaritza
CHAPTER 9 CONSENT
Consent is an ethical imperative of great importance to managers and clinicians. It is clear that patients want to be more involved in medical decision making. The issues that consent raises suggest both a problem and a goal for health services providers.
The concept of consent in medical care evolved to protect patients from nonconsensual touching. Although the ethical and legal dimensions overlap, the legal requirements of consent are the minimum expected. The ethics of consent are grounded in the principle of respect for persons, specifically the element of autonomy, which reflects a view of the equality and dignity of human beings. In addition, the ethics of consent reflect the special relationship of trust and confidence between physician and patient and between organization and patient. This fiduciary relationship is supported by the principles of beneficence and nonmaleficence. The manager's virtues of trustworthiness, honesty, integrity, and candor also support the ethics of consent.
According to the law, failure to obtain consent can support a legal action for battery, an intentional tort. Beyond this, an action for negligence can be brought if the physician breaches the duty to communicate information necessary for the patient to give informed consent.
Paternalism stems from beneficence and is the ethical value that competes with patient autonomy in implementing consent. Paternalism arises naturally from the relationship between physician and patient because psychologically, technically, and emotionally, the physician is in a position of superior knowledge and is expected to help choose the best course of action for the patient. This reflects the ethics of care discussed in Chapter 1. The paternalism inherent in the physician–patient relationship was first described in the Hippocratic oath. Beneficence, nonmaleficence, and paternalism continue to be important and are implicit elements of the practice of medicine. The revisions of the Principles of Medical Ethics adopted by the American Medical Association (AMA) in 1980 moved organized medicine from paternalism toward autonomy and patient rights, themes that continued in the 2001 revision. The AMA's Council on Ethical and Judicial Affairs amplified these themes in its Fundamental Elements of the Patient–Physician Relationship statement. This document and the 2001 Principles of Medical Ethics are reproduced in Appendix B.
Specialized codes that guide biomedical research (e.g., the Declaration of Helsinki) also recognize the importance of consent. The emphasis on patients' rights or sovereignty in documents such as these are ideals toward which managers and organizations should strive.
LEGAL ASPECTS
Legally, consent must be voluntary, competent, and informed. The law presumes that persons unable to give consent in an emergency want to receive treatment. The presumption of wanting treatment can be rebutted if a competent patient declines it or if the person requiring ...
Write a 100-word reply to the 4 individual questions below. .docxlindorffgarrik
**Write a 100-word reply to the 4 individual questions below.**
To help you with your discussion, please consider the following questions:
What clarification do you need regarding the posting?
What differences or similarities do you see between your posting and other classmates' postings?
What additional questions do you have after reading the posting?
What item you found to be compelling and enlightening.
1.Katrina- In my opinion the court decision is warranted because, doctors are not obligated to disclose to patients “miracle treatments” or any drug or treatment not yet approved by the FDA. Now there are cases where FDA approved drugs have been used in specific treatments that isn’t approved for that particular drug this is called “off label drugs”. The use of non-FDA approve medicines increases the physician chance of medical malpractice liability. These particular drugs and/or treatment were illegal and not approved by the FDA in the patient state of resident for a reason. Non-FDA approved prescription drugs may present a significant threat to individuals seeking care since these drugs most certainly has not endured evaluation by the FDA for “safety, effectiveness or quality” (FDA.gov). If the FDA did not evaluate drugs, there wouldn’t be any means to determine if these medicines are harmless and beneficial for use. The FDA also evaluates to make certain that prescription drugs are formulated in a way that the drug quality is consistent and if the drugs label is absolute and accurate. FDA unapproved drugs have ensued in injury to the patient. The FDA focus on protecting patients from the injuries associated with non-approved drugs. These standards are put in place to protect both the patient and the physician.
The treating physician need not to be held accountable for not advising patients of treatment options that are illegal or not successfully proven because, technically these treatment options are not available to the patient. The informed consent doctrine requires the physician to inform the patient of the benefits, inherent, material risks, and alternatives of a medical intervention. “The doctrine of informed consent is the legal basis for informed consent and is usually outlined in a state’s medical practice acts” (Judson, K 2020). Informed consent entails the patient’s right to receive all pertinent information in relation to the condition and then to make a decision regarding treatment based on that knowledge. (Judson, K 2020). The informed consent doctrine does not include disclosure for illegal treatments or illegal prescription drugs. “The physician's obligation is to give medical facts accurately to the patient and to make recommendations for management in accordance with good medical practice” (AMA 2010). Disclosing illegal treatment options or even illegal prescription drugs do not fall under good medical practices and the physician should not be held responsible for not disclosing this information.
To Prepare· Review the Congress website provided in the ResourcTakishaPeck109
To Prepare:
· Review the Congress website provided in the Resources and identify one recent (within the past 5 years) proposed health policy.
· Review the health policy you identified and reflect on the background and development of this health policy.
Post a description of the health policy you selected and a brief background for the problem or issue being addressed. Explain whether you believe there is an evidence base to support the proposed policy and explain why. Be specific and provide examples.
APA format and 3 references
Then respond to a peer with 2 references
Peer 1
The healthcare policy I chose is S. 3098, S.3098 -is the Preventive Care Awareness Act of 2021.
S. 3098 will provide national public health information and focus on people in a lower income bracket who have forgone services during the COVID-19 pandemic. This bill would also create a task force to promote preventative care and development programs in rural and underserved populations. Its primary focus is teaching low-income Americans the benefits of preventive healthcare. This bill is in committee and has bipartisan support (Bell et al., 2017).
Reading this proposed bill, I asked myself whether it is lower-income Americans who have forgone preventative treatment during COVID or Americans in general. Preventive screenings have long been advocated as one of the most valuable ways to facilitate early diagnosis and treatment of disease. Cancer screenings have helped lower the US cervical cancer death rate by 50% in the last three decades (2022).
According to the American Medical Association, more than 40% of Americans surveyed stopped preventative medical care as covid-19 began (Timothy M. Smith, Senior News Writer, 2020). This number included Americans of all economic levels. I believe no proof was found that only lower-income Americans skipped screenings during the height of the COVID-19 pandemic.
According to the Joint Commission, patients with lower health literacy did not see the importance of preventative care during COVID-19 (The Joint Commission, 2022). I believe there is evidence-based support for increasing education for all Americans regarding the importance of preventive health screenings, And indeed more teaching to Americans with a lower understanding of their health. This bill was given only a 3% chance of passing into law. I believe that is partly because it only attempts to reach lower-income populations and not all Americans.
50 words minimum each response
R1
I had a hard time with this question. I'd like to believe that all, if not most, health care providers have very high empathy, which would cause them to be sensitive toward patients. However, many different people with different personalities become health providers, and laws and regulations provide boundaries for most people. I believe if left alone, healthcare professionals and other professionals would choose what is most convenient for them and not what is best for the patie ...
Patients Rising: How to Reach Empowered, Digital Health Consumerse-Patient Connections
Kru Research's white paper discussing how to reach out to empowered, digital, health consumers or e-Patients. Discussion of participatory medicine, digital health consumers, e-Patients, web 2.0, the power of social media, ROI of social media, regulatory concerns, HIPAA, FDA, adverse event reporting, and the future of social media in health marketing.
CHAPTER 9 CONSENTConsent is an ethical imperative of great impo.docxchristinemaritza
CHAPTER 9 CONSENT
Consent is an ethical imperative of great importance to managers and clinicians. It is clear that patients want to be more involved in medical decision making. The issues that consent raises suggest both a problem and a goal for health services providers.
The concept of consent in medical care evolved to protect patients from nonconsensual touching. Although the ethical and legal dimensions overlap, the legal requirements of consent are the minimum expected. The ethics of consent are grounded in the principle of respect for persons, specifically the element of autonomy, which reflects a view of the equality and dignity of human beings. In addition, the ethics of consent reflect the special relationship of trust and confidence between physician and patient and between organization and patient. This fiduciary relationship is supported by the principles of beneficence and nonmaleficence. The manager's virtues of trustworthiness, honesty, integrity, and candor also support the ethics of consent.
According to the law, failure to obtain consent can support a legal action for battery, an intentional tort. Beyond this, an action for negligence can be brought if the physician breaches the duty to communicate information necessary for the patient to give informed consent.
Paternalism stems from beneficence and is the ethical value that competes with patient autonomy in implementing consent. Paternalism arises naturally from the relationship between physician and patient because psychologically, technically, and emotionally, the physician is in a position of superior knowledge and is expected to help choose the best course of action for the patient. This reflects the ethics of care discussed in Chapter 1. The paternalism inherent in the physician–patient relationship was first described in the Hippocratic oath. Beneficence, nonmaleficence, and paternalism continue to be important and are implicit elements of the practice of medicine. The revisions of the Principles of Medical Ethics adopted by the American Medical Association (AMA) in 1980 moved organized medicine from paternalism toward autonomy and patient rights, themes that continued in the 2001 revision. The AMA's Council on Ethical and Judicial Affairs amplified these themes in its Fundamental Elements of the Patient–Physician Relationship statement. This document and the 2001 Principles of Medical Ethics are reproduced in Appendix B.
Specialized codes that guide biomedical research (e.g., the Declaration of Helsinki) also recognize the importance of consent. The emphasis on patients' rights or sovereignty in documents such as these are ideals toward which managers and organizations should strive.
LEGAL ASPECTS
Legally, consent must be voluntary, competent, and informed. The law presumes that persons unable to give consent in an emergency want to receive treatment. The presumption of wanting treatment can be rebutted if a competent patient declines it or if the person requiring ...
Write a 100-word reply to the 4 individual questions below. .docxlindorffgarrik
**Write a 100-word reply to the 4 individual questions below.**
To help you with your discussion, please consider the following questions:
What clarification do you need regarding the posting?
What differences or similarities do you see between your posting and other classmates' postings?
What additional questions do you have after reading the posting?
What item you found to be compelling and enlightening.
1.Katrina- In my opinion the court decision is warranted because, doctors are not obligated to disclose to patients “miracle treatments” or any drug or treatment not yet approved by the FDA. Now there are cases where FDA approved drugs have been used in specific treatments that isn’t approved for that particular drug this is called “off label drugs”. The use of non-FDA approve medicines increases the physician chance of medical malpractice liability. These particular drugs and/or treatment were illegal and not approved by the FDA in the patient state of resident for a reason. Non-FDA approved prescription drugs may present a significant threat to individuals seeking care since these drugs most certainly has not endured evaluation by the FDA for “safety, effectiveness or quality” (FDA.gov). If the FDA did not evaluate drugs, there wouldn’t be any means to determine if these medicines are harmless and beneficial for use. The FDA also evaluates to make certain that prescription drugs are formulated in a way that the drug quality is consistent and if the drugs label is absolute and accurate. FDA unapproved drugs have ensued in injury to the patient. The FDA focus on protecting patients from the injuries associated with non-approved drugs. These standards are put in place to protect both the patient and the physician.
The treating physician need not to be held accountable for not advising patients of treatment options that are illegal or not successfully proven because, technically these treatment options are not available to the patient. The informed consent doctrine requires the physician to inform the patient of the benefits, inherent, material risks, and alternatives of a medical intervention. “The doctrine of informed consent is the legal basis for informed consent and is usually outlined in a state’s medical practice acts” (Judson, K 2020). Informed consent entails the patient’s right to receive all pertinent information in relation to the condition and then to make a decision regarding treatment based on that knowledge. (Judson, K 2020). The informed consent doctrine does not include disclosure for illegal treatments or illegal prescription drugs. “The physician's obligation is to give medical facts accurately to the patient and to make recommendations for management in accordance with good medical practice” (AMA 2010). Disclosing illegal treatment options or even illegal prescription drugs do not fall under good medical practices and the physician should not be held responsible for not disclosing this information.
Similar to David Harlow on Social Media In Health Care Legal Issues - OHA PRMS 111209 (20)
Telemedicine challenges and opportunities slidecastDavid Harlow
Slidecast of preso at http://www.slideshare.net/DavidHarlow/telemedicine-challenges-and-oppoertunities See slides at that link for live links to other resources.
Beyond HIPAA: Digital Health Opportunities & Regulatory Land MinesDavid Harlow
An overview of state and federal regulatory schemes that affect digital health - beyond HIPAA - together with a discussion of the opportunites presented and strategies for dealing with the regulatory environment
Health Data Privacy (and a little FDA mHealth) RegulationDavid Harlow
I spoke at the Cambridge, MA Health Innovators Meetup January 20-15 meeting, The overall theme of the meeting was Launching & Funding Healthcare Innovation: Legal & Business Considerations. I focused on health data privacy and security and the FDA guidance on determining when an mHealth app is a medical device. A good time was had by all.
MCLE Health Law Basics Plus 2013 - Post-Acute CareDavid Harlow
My annual presentation at the Massachusetts Continuing Legal Education two-day extravaganza intro to health law.
See resources collected at http://j.mp/MCLEHealthLaw
Patient Consent to the Use of Data: Are We Asking the Wrong Question?David Harlow
In this presentation at #StrataRx 2013 I explore the notion of building big data analytics on top of a data store populated by health record information obtained as a result of patient requests. Why? Because doing it that way would bring the data out from under HIPAA and HITECH regulations. Patients could contribute as much or as little of the data as they wish, patients could be compensated for their contributions, and other pesky HIPAA restrictions would fall by the wayside. I used one company's newly-announced service as an example, but there are others in this space as well.
See livetweets of presentation at: http://www.healthblawg.com/2013/09/david-harlows-hipaa-and-hitech-presentation-at-stratarx.html
Press coverage of this presentation: Solving Healthcare's Big Data Analytics Security Conundrum - CIO.com – http://shrd.by/8qCxmo
Health Care Social Media - An Introduction to Engaging Intelligently and LegallyDavid Harlow
Learn more about the value of social media tools, the range of issues they present, and some key strategies for using these tools effectively while steering clear of trouble by social media expert and charter member of the Advisory Board of the Mayo Clinic Center for Social Media, David Harlow.
Engage David Harlow as a keynote speaker or consultant to your organization: http://bit.ly/tgQhmU
One recent review: '@healthblawg is so good I just tend to listen vs tweet'
You may purchase the audio and a transcript of this webinar at http://bit.ly/uqBiBi
Health Care Social Media for Medical Device Manufacturers - FDA - Presentatio...David Harlow
Health Care Social Media in the Face of Continued FDA Regulatory Uncertainty for Medical Device Manufacturers, Presented at MassMEDIC conference 05 13 2011
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
David Harlow on Social Media In Health Care Legal Issues - OHA PRMS 111209
1. New Media: Same Old Potential Pitfalls Harnessing New Media Tools PRMS Session at Oklahoma Hospital Association Annual Meeting November 12, 2009 David Harlow JD MPH THE HARLOW GROUP LLC
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Editor's Notes
7/23/2009 harlowgroup.net @healthblawg David Harlow
7/23/2009 harlowgroup.net @healthblawg David Harlow
David Harlow 7/23/2009 harlowgroup.net @healthblawg
David Harlow 7/23/2009 harlowgroup.net @healthblawg
David Harlow 7/23/2009 harlowgroup.net @healthblawg
David Harlow 7/23/2009 harlowgroup.net @healthblawg
David Harlow 7/23/2009 harlowgroup.net @healthblawg
David Harlow 7/23/2009 harlowgroup.net @healthblawg
David Harlow 7/23/2009 harlowgroup.net @healthblawg
David Harlow 7/23/2009 harlowgroup.net @healthblawg
7/23/2009 harlowgroup.net @healthblawg David Harlow
7/23/2009 harlowgroup.net @healthblawg David Harlow